OakChart

Fresenius Medical Care AG ADR

FMSHealthcare·Medical Care Facilities·Germany·Large·NYSE·Nov 11 • 9:46 AM ET

22.67-0.07 (-0.31%)
2026-11-11 15:47 CET
Market cap
11,802.49 USD m
Revenue, TTM
22,628.26 USD m
Net income, TTM
955.84 USD m
Free cash flow, TTM
2,077.06 USD m
EPS diluted, TTM
1.74
P/E
13.04
Compare

Price

FMS against its 20, 50 and 200-day averages
2050200miss
20.0022.0024.0026.003.1M6.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26FMSclose 22.6720-day 22.5350-day 22.33200-day 22.9122.67

16.5% under 27.16 on 30 Oct 2025. Last 15 sessions, 11.0% high to low

Profile

FMS
52-week range, 41% of the way up
20.0226.42

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Employees111024
IPOSep 17, 1996
Beta0.74
ATR, 14d0.56
Rel volume1.09
Short float0.58%
Insider own0.00%
Inst own8.68%

Snapshot

6 groups

Valuation

Index-
Market Cap11.77B
Enterprise Value23.98B
Income955.84M
Sales22.63B
Book/sh28.00
Cash/sh2.41
Dividend Est.0.81 (3.58%)
Dividend TTM0.86 (3.81%)
Dividend Ex-DateMay 22, 2026
Dividend Gr. 3/5Y13.25% 1.37%
Payout31.98%
Employees111024
IPOSep 17, 1996

Ratios

P/E13.04
Forward P/E10.31
PEG14.13
P/S0.52
P/B0.81
P/C9.42
P/FCF5.66
EV/EBITDA5.69
EV/Sales1.06
Quick Ratio0.69
Current Ratio0.99
Debt/Eq0.85
LT Debt/Eq0.62
Option/ShortYes / Yes

Earnings

EPS (ttm)1.74
EPS next Y2.20
EPS next Q0.56
EPS this Y-9.28%
EPS next Y-3.84%
EPS next 5Y0.73%
EPS past 3/5Y16.25% -3.43%
Sales past 3/5Y2.83% 1.71%
EPS Y/Y TTM26.14%
Sales Y/Y TTM4.27%
EPS Q/Q-36.42%
Sales Q/Q-0.50%
EarningsNov 03 BMO
EPS/Sales Surpr.-4.61% 0.04%

Ownership

Insider Own0.00%
Insider Trans-
Inst Own8.68%
Inst Trans0.53%
ROA2.65%
ROE6.43%
ROIC4.06%
Gross Margin26.46%
Oper. Margin11.23%
Profit Margin4.22%
SMA200.63%
SMA501.52%
SMA200-1.06%
Trades-

Technical

Shs Outstand519.02M
Shs Float519.01M
Short Float0.58%
Short Ratio3.09
Short Interest3.01M
52W High26.42 -14.20%
52W Low20.02 13.23%
Volatility1.87% 1.95%
ATR (14)0.56
RSI (14)51.24
Beta0.74
Rel Volume1.09
Avg Volume972.45K
Volume96,715

Performance

Perf Week-2.24%
Perf Month7.54%
Perf Quarter-4.06%
Perf Half Y5.98%
Perf YTD-4.83%
Perf Year-5.50%
Perf 3Y31.88%
Perf 5Y-31.80%
Perf 10Y-43.11%
Recom4.00
Target Price20.38
Prev Close22.74
Price22.67
Change %-0.31%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 09, 2026DowngradeBBarclaysEqual Weight → Underweight
Sep 29, 2026DowngradeBBerenbergBuy → Hold
Jul 28, 2026DowngradeBBNP Paribas ExaneNeutral → Underperform$19.90-12.2%
Jul 16, 2026InitiatedBBernsteinMkt Perform
Jan 20, 2026DowngradeGGoldmanBuy → Neutral
Oct 15, 2025DowngradeBBofA SecuritiesNeutral → Underperform
Sep 02, 2025DowngradeUUBSNeutral → Sell
Dec 02, 2024UpgradeBBofA SecuritiesUnderperform → Neutral
Nov 06, 2024InitiatedBBerenbergBuy$25.60+12.9%
Jan 08, 2024DowngradeMMorgan StanleyEqual-Weight → Underweight

Peers

Mkt cap
TickerCompanyMkt cap
DVADaVita Inc11.32B
OPCHOption Care Health Inc4.74B
THCTenet Healthcare Corp22.86B
UHSUniversal Health Services Inc11.16B
HCAHCA Healthcare Inc104.59B
EHCEncompass Health Corp13.81B
ENSGEnsign Group Inc10.75B
CHEChemed Corp7.05B
OMOutset Medical Inc78.42M
ARDXArdelyx Inc759.14M

Held by

AUM
TickerCompanyAUM
PZLVPzena U.S. Large Cap Value ETFAUM: 73.80M
AVDEAvantis International Equity ETFAUM: 19.73B
BFLXiShares Flexible Equity Active ETFAUM: 2.15B
APIEActivePassive International Equity ETFAUM: 1.13B
TIIVAAM Todd International Intrinsic Value ETFAUM: 31.97M
CVARCultivar ETFAUM: 47.77M
DFAIDimensional International Core Equity Market ETF-
DFIVDimensional International Value ETF-
AVSDAvantis Responsible International Equity ETFAUM: 379.33M
AVNCAvantis All International Core Equity ETFAUM: 98.25M

News

latest 14 of 206
  • Barclays sees Fresenius Medical Care earnings hit by reimbursement pressures (Investing.com)
  • Fresenius Medical Care reports third quarter 2026 performance partially offsetting headwinds and narrowing full year outlook (PR Newswire)
  • Fresenius: Q3 Earnings Snapshot (Associated Press)
  • Fresenius Medical Care's Q3 Test: Can Margin Gains Outrun A Self-Inflicted US Volume Slump? (Earnings Whispers)
  • Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO (PR Newswire)
  • Loading…
  • Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026 (PR Newswire)
  • Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth (PR Newswire) -7.72%
  • Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership (PR Newswire)
  • Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis (PR Newswire)
  • Fresenius Medical Care AG (FMS) (Q2 2026) Earnings Call Highlights: Strong Profit Growth and ... (GuruFocus.com)
  • Fresenius Medical Care Shares Slide Despite Second-Quarter Earnings Beat (InvestorsHub)
  • Fresenius: Q2 Earnings Snapshot (Associated Press)
  • Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-030.6210.6510.3415,5275,5246
2026Q22026-08-030.6470.6160.4735,6025,4805
2026Q12026-05-050.5330.6040.2505,3995,4065
2025Q42026-02-240.8480.6470.6665,9695,6715
2025Q32025-11-040.6320.5940.5505,6145,7485
2025Q22025-08-050.5260.5060.4355,5425,7155
2025Q12025-05-060.4760.4260.2715,5365,2995
2024Q42025-02-250.4780.4230.1225,3214,9494
2024Q32024-11-050.4470.3780.3995,2555,3855
2024Q22024-07-300.3780.3710.3435,1255,4355
2024Q12024-05-070.3610.2840.1315,0934,9265
2023Q42024-02-200.4760.4370.3445,3995,3636
2023Q32023-11-010.3030.2880.1565,2415,2044
2023Q22023-08-020.3220.2890.2605,2725,3025
2023Q12023-05-090.2910.2430.1585,1615,1376
2022Q42023-02-220.4560.3060.2425,2955,3016

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY2.4392.3342.21818,70219,245
2020FY2.7052.7182.25521,71621,732
2021FY1.9721.9761.95519,97020,060
2022FY1.6481.5411.20720,55520,665
2023FY1.3961.2890.91921,05621,085
2024FY1.6321.4980.99220,42320,047
2025FY2.5202.2771.97823,10923,001
2026FY-2.286--21,918
2027FY-2.198--22,624
2028FY-2.575--23,420
2029FY-3.108--24,385
2030FY-3.512--25,391

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-065045,6145,4925,744
2026Q4S2026-11-045135,7865,5836,351
2026Q4S2026-11-035135,8215,5836,351
2026Q4S2026-11-025225,8545,5906,351
2026Q4S2026-10-195225,8545,5906,351
2026Q4S2026-10-185215,8565,5906,351
2026Q4S2026-10-155225,8565,5906,351
2026Q4S2026-10-095225,8585,5986,351
2026Q4S2026-10-065225,8645,5986,351
2026Q4S2026-09-295225,8875,5986,351
2026Q4S2026-09-175225,8575,5986,205
2026Q4S2026-09-025315,8765,5986,205
2026Q4S2026-08-245325,8765,5986,205
2026Q4S2026-08-105325,8615,5986,205

Estimate history

EPS, annual2.3493.8052.2182.2551.9551.2070.9190.9921.8961.7379
Period201720182019202020212022202320242025TTM
EPS, quarterly0.3990.1220.2710.4350.550.6660.250.4730.35
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual20058.70619521.66819559.12120364.13320824.62420383.98221032.14920917.46422161.73522628.26
Period201720182019202020212022202320242025TTM
Sales, quarterly5229.2525424.1315137.5515431.1795708.5665901.1365395.8775651.4275679.817
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual612.902613.757596.658585.753586.009586.827586.827586.827558.578519.019
Period201720182019202020212022202320242025MRQ
Shares, quarterly586.827586.827586.827586.827579.698558.578540.177532.219519.019
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue22,628.2622,161.7420,917.4621,032.1520,383.9820,824.6220,364.1319,559.1219,521.67
Cost of Goods Sold Incl. D&A16,641.1716,475.7415,764.6915,698.5614,803.6814,824.0814,043.2913,524.1213,437.69
Gross Profit5,987.095,685.995,152.775,333.595,580.306,000.546,320.846,035.006,083.98
Selling, General and Administrative Excl. Other3,446.693,559.203,374.433,617.583,737.313,638.503,801.563,640.663,326.79
Research and Development183.92178.29198.48250.79240.28260.96220.90188.07157.63
Other Operating Expense---0.000.000.000.000.000.00
Operating Income2,540.412,126.791,778.341,716.011,842.992,362.042,519.282,394.342,757.19
Interest Expense449.99399.81429.50443.14364.84416.20463.03517.93404.71
Unusual Expense587.3138.86527.05318.27444.27247.6739.1618.70212.61
Net Income Before Taxes1,558.561,501.99997.37985.141,211.481,748.962,099.691,977.083,142.13
Income Taxes367.39362.24341.87324.94341.52417.04570.62449.51602.95
Consolidated Net Income1,261.331,344.44801.39791.87939.911,440.871,636.811,610.042,625.72
Net Income From Continuing Operations955.841,104.16581.86539.47707.731,145.701,327.361,342.672,338.17
Net Income955.841,104.16581.86539.47707.731,145.701,327.361,342.672,338.17
EPS (Recurring)2.601.941.621.301.742.252.302.244.05
EPS (Basic, Before Extraordinaries)1.741.900.990.921.211.962.262.223.81
EPS (Diluted)1.741.900.990.921.211.952.262.223.81
EBITDA4,213.223,778.373,439.313,459.573,650.814,235.924,328.274,132.993,612.33
Non-Operating Income (Expense)55.46-186.14175.5830.54177.6050.7982.61119.371,002.26
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-----0.005.361.56-
Price To Earnings Ratio13.0813.0818.5925.5211.5916.5818.4816.608.48
Price To Sales Ratio0.520.630.640.580.470.911.201.141.02
Gross Margin26.4625.6624.6325.3627.3828.8131.0430.8631.17
Operating Margin11.239.608.508.169.0411.3412.3712.2414.12
Net Margin4.224.982.782.563.475.506.526.8611.98
Shares Outstanding519.02558.58586.83586.83586.83586.01585.75596.66613.76
Market Capitalization11,802.4911,802.4913,285.7412,223.599,588.7419,021.8223,363.5422,124.5219,808.95

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue5,679.825,651.435,395.885,901.145,708.575,431.185,137.555,424.13
Cost of Goods Sold Incl. D&A4,212.484,128.304,015.964,284.434,256.884,054.763,891.464,068.36
Gross Profit1,467.341,523.131,379.921,616.701,451.691,376.421,246.091,355.77
Selling, General and Administrative Excl. Other814.34894.92793.45943.97869.63925.91823.45858.63
Research and Development47.6346.0844.8245.3944.1143.2045.7653.33
Other Operating Expense0.000.000.00-0.00-0.00-
Operating Income653.00628.20586.47672.73582.06450.51422.64497.14
Interest Expense112.18113.43109.15115.23108.79109.47100.74107.74
Unusual Expense205.9138.01292.1851.2213.5813.30109.25249.17
Net Income Before Taxes327.29493.29194.43543.56415.91346.13213.46156.80
Income Taxes89.55104.4550.02123.3887.9188.7064.2565.07
Consolidated Net Income258.63340.87192.76469.06382.54308.63199.56125.87
Net Income From Continuing Operations183.83253.91137.50380.61321.14255.33159.1571.47
Net Income183.83253.91137.50380.61321.14255.33159.1571.47
EPS (Recurring)0.620.520.620.730.570.450.400.42
EPS (Basic, Before Extraordinaries)0.350.470.250.670.550.440.270.12
EPS (Diluted)0.350.470.250.670.550.440.270.12
EBITDA1,062.361,043.481,000.511,106.881,000.68860.86825.311,005.95
Non-Operating Income (Expense)-7.6316.529.3037.27-43.7718.390.8016.58
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Price To Earnings Ratio13.0811.9011.7417.2821.4625.1725.0318.59
Price To Sales Ratio0.520.540.550.610.710.790.700.64
Gross Margin25.8326.9525.5727.4025.4325.3424.2525.00
Operating Margin11.5011.1210.8711.4010.208.298.239.17
Net Margin3.244.492.556.455.634.703.101.32
Shares Outstanding519.02532.22540.18558.58579.70586.83586.83586.83
Market Capitalization11,802.4911,089.7512,601.5013,808.3815,301.1516,765.6214,611.9713,285.74

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2,027.861,376.751,701.831,540.861,840.011,521.151,280.822,575.591,188.69
Short Term Receivables4,213.743,948.404,335.094,145.924,266.874,262.384,290.164,304.614,438.34
Inventories2,676.572,272.962,606.812,663.802,524.872,660.121,990.591,739.401,611.55
Other Current Assets276.48494.23817.78247.74252.79292.36315.96350.58415.69
Total Current Assets9,194.668,092.349,461.518,598.328,884.538,736.017,877.548,970.177,654.27
Net Property, Plant & Equipment7,633.687,516.268,234.088,900.669,724.7310,016.909,558.534,385.134,192.92
Total Investments and Advances1,554.361,466.981,385.80825.76894.87931.26782.24742.80776.93
Long-Term Note Receivable201.69227.50285.90308.11344.74320.94313.67137.94108.49
Intangible Assets17,412.2617,127.9317,688.0318,473.9517,991.6117,545.3917,335.4214,736.2715,354.60
Deferred Tax Assets277.81237.66313.67333.71358.63429.65405.44395.17378.45
Other Assets136.2289.53111.57718.07882.55792.97696.39631.36383.82
Total Assets36,410.6934,758.1937,480.5638,158.5839,081.6538,773.1236,969.2429,998.8528,849.48
Short Term Debt Incl. Current Port. of LT Debt2,580.661,261.511,724.982,173.882,940.112,076.103,656.922,858.691,984.70
Accounts Payable866.27936.38841.82867.95837.06895.63804.30733.07709.06
Income Tax Payable163.95147.72211.28153.61156.75144.85114.2678.0060.65
Other Current Liabilities3,723.693,515.383,973.093,706.804,319.464,420.053,290.143,495.833,609.70
Total Current Liabilities7,334.565,860.996,751.176,902.248,253.387,536.637,865.627,165.596,364.11
Long Term Debt10,098.2410,107.1411,586.5111,927.2412,207.5613,071.4711,813.885,767.786,958.48
Provision for Risks Charges878.67906.26927.49757.421,098.44996.05895.75777.77856.64
Deferred Tax Liabilities809.81734.06828.80999.45987.60961.57830.32716.21561.42
Other Liabilities514.96821.451,008.461,084.10637.711,119.43716.10822.631,106.33
Total Liabilities19,636.2418,429.9021,102.4321,670.4423,184.6923,685.1522,121.6715,249.9815,846.99
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity15,631.7315,094.0315,045.6214,930.2414,441.0613,722.2113,422.7613,441.6311,791.98
Total Shareholders Equity15,631.7315,094.0315,045.6214,930.2414,441.0613,722.2113,422.7613,441.6311,791.98
Accumulated Minority Interest1,142.711,234.261,332.511,557.891,455.901,365.761,424.821,307.251,210.51
Total Equity16,774.4516,328.3016,378.1316,488.1415,896.9615,087.9714,847.5714,748.8713,002.49
Total Liabilities & Stockholders Equity36,410.6934,758.1937,480.5638,158.5839,081.6538,773.1236,969.2429,998.8528,849.48
Book Value Per Share27.9825.7225.6425.4424.6423.4322.5021.9019.24
Tangible Book Value Per Share-3.19-3.47-4.50-6.04-6.06-6.53-6.56-2.11-5.81
Full-Time Employees111,024113,840119,845128,044122,909125,364120,659112,658114,000
Price to Book Ratio0.810.870.820.651.321.771.641.482.82
Return on Assets3.101.611.431.832.943.504.017.955.18
Return on Equity7.193.863.604.828.149.7810.0018.5312.94
Return on Invested Capital4.292.312.032.644.304.955.3212.177.70
Quick Ratio0.890.991.020.860.770.810.751.010.95
Current Ratio1.251.381.401.251.081.161.001.251.20

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,254.091,344.44801.39791.87939.911,440.871,636.811,610.042,625.72
Depreciation1,655.681,651.581,660.971,743.551,807.821,873.871,808.991,738.65855.14
Other Funds (Non Cash)89.36-95.60-283.30-168.14-291.69-336.14214.71-108.24-1,089.29
Funds from Operations2,856.092,869.702,100.462,235.232,412.453,058.103,787.163,312.382,496.77
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital480.41156.01480.61606.80-134.60-115.561,038.53-439.32-64.23
Income Taxes Payable426.69267.04521.67510.38342.28370.80---
Cash from Operating Activities3,336.503,025.722,581.072,842.042,277.862,942.544,825.692,873.062,432.54
Capital Expenditures-1,259.44-1,038.33-765.73-768.63-809.60-1,048.08-1,237.14-1,301.42-1,347.72
Net Assets From Acquisitions-18.74-18.65-0.19-3.40-50.00-406.98-256.03-2,479.48-299.07
Sale of Fixed Assets and Businesses117.55281.06720.03249.69255.36179.3098.64199.441,956.01
Purchase or Sale of Investments-40.99-6.80-22.40-19.96-74.91-72.78-74.17-20.12-519.12
Purchase of Investments-159.76-101.03-103.68-116.82-135.53-243.60-122.32-38.73-696.29
Sale Or Maturity of Investments118.7794.2381.2796.8660.61170.8248.1518.61177.17
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.09
Cash from Investing Activities-1,206.91-782.72-68.30-542.30-679.16-1,348.54-1,468.69-3,601.59-209.81
Cash Dividends Paid-467.85-476.84-377.69-355.28-415.72-463.87-400.32-396.93-383.23
Change in Capital Stock-1,395.26-660.540.000.0021.187.70-402.79-653.5712.01
Repurchase of Common Pref Stock-1,395.26-660.540.000.000.000.00-417.22-671.32-43.91
Sale of Common Pref Stock0.000.000.000.0021.187.7014.4217.7655.92
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net623.27901.30-1,329.00-499.93-360.33399.57-640.881,126.29189.85
Change in Long Term Debt298.54883.64-836.09-305.72254.65-991.57609.531,392.12-547.19
Issuance of Long Term Debt865.281,831.1866.54451.771,037.231,470.502,417.783,873.50722.46
Reduction of Long Term Debt-566.74-947.54-902.63-757.50-782.58-2,462.07-1,808.25-2,481.38-1,269.65
Net Financing Active Other Cash Flow-361.63-647.77-364.30-413.77-223.28-395.78-843.7195.43-702.19
Other Financing Activities Uses-361.63-647.77-364.30-413.77-323.09-395.78-843.71-331.49-702.19
Cash from Financing Activities-2,326.28-1,616.34-2,802.77-2,055.36-1,792.82-1,276.17-3,090.03-598.53-883.55
Exchange Rate Effect4.66-159.6728.34-78.50-24.34155.11-182.8253.4638.21
Net Change in Cash-192.03466.99-261.66165.88-218.46472.9384.15-1,273.601,377.38
Free Cash Flow2,077.061,992.651,824.582,101.911,516.971,932.703,626.461,614.141,185.22
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow7.319.159.187.008.7012.957.5818.3224.82
Deferred Taxes & Investment Tax Credit--30.71-78.61-132.06-43.5879.50126.6671.93105.20

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments1,248.431,213.331,427.742,027.861,475.742,013.25
Short Term Receivables3,918.503,961.784,280.924,213.743,848.133,793.23
Inventories2,741.192,666.002,653.522,676.572,451.632,343.00
Other Current Assets996.82950.05979.80276.481,418.171,400.68
Total Current Assets8,904.938,791.169,341.989,194.669,193.679,550.16
Net Property, Plant & Equipment7,252.147,351.017,423.977,633.687,517.787,628.33
Total Investments and Advances1,551.821,550.571,532.801,554.361,602.491,571.03
Intangible Assets17,350.0617,433.0417,401.8317,412.2617,431.3117,459.98
Deferred Tax Assets342.18312.83287.46277.81271.16271.61
Other Assets320.44338.95268.92136.22275.82250.04
Total Assets35,721.5935,777.5636,256.9636,410.6936,292.2336,731.16
Short Term Debt Incl. Current Port. of LT Debt3,378.482,658.442,752.382,580.661,336.321,882.12
Accounts Payable881.34926.64888.17866.27852.87804.29
Income Tax Payable302.38266.21174.89163.95203.68196.69
Other Current Liabilities4,417.244,354.803,938.313,723.694,374.453,761.56
Total Current Liabilities8,979.448,206.097,753.757,334.566,767.326,644.65
Long Term Debt8,986.949,875.959,955.7010,098.2410,969.0611,059.05
Provision for Risks Charges839.34888.00661.59878.67691.22738.17
Deferred Tax Liabilities747.82769.56810.34809.81782.22719.51
Other Liabilities541.61567.68708.93514.96740.04752.23
Total Liabilities20,095.1520,307.2819,890.3119,636.2419,949.8519,913.61
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity14,530.5614,356.0915,257.2215,631.7315,214.8415,578.06
Total Shareholders Equity14,530.5614,356.0915,257.2215,631.7315,214.8415,578.06
Accumulated Minority Interest1,095.881,114.201,109.441,142.711,127.541,239.48
Total Equity15,626.4415,470.2816,366.6516,774.4516,342.3816,817.54
Total Liabilities & Stockholders Equity35,721.5935,777.5636,256.9636,410.6936,292.2336,731.16
Book Value Per Share28.0026.9728.2427.9826.2526.55
Tangible Book Value Per Share-5.43-5.78-3.97-3.19-3.82-3.21
Full-Time Employees106,291107,226108,165109,698109,916112,445
Price to Book Ratio0.810.800.810.910.991.08
Return on Assets2.653.023.063.142.221.97
Return on Equity6.437.307.117.275.314.72
Return on Invested Capital0.781.050.551.481.230.96
Quick Ratio0.690.750.860.891.001.08
Current Ratio0.991.071.201.251.361.44

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income258.39342.68192.76460.25387.54302.40
Depreciation409.07417.37414.04415.20433.76394.22
Other Funds (Non Cash)-52.01-41.0189.5592.84-66.58-116.30
Funds from Operations541.81658.06684.32971.89777.98554.68
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital378.46347.70-418.88173.1495.55292.85
Income Taxes Payable155.62201.0830.0939.8968.97103.89
Cash from Operating Activities920.271,005.76265.441,145.03873.53847.53
Capital Expenditures-273.89-280.96-222.36-482.23-211.88-183.07
Net Assets From Acquisitions-13.37-2.24-5.462.33-21.040.00
Sale of Fixed Assets and Businesses33.969.5512.1761.87172.5919.27
Purchase or Sale of Investments15.54-38.3524.15-42.33-1.4314.46
Purchase of Investments0.07-87.00-0.08-72.75-16.28-0.22
Sale Or Maturity of Investments15.4748.6524.2330.4214.8514.68
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-237.76-312.01-191.50-465.64-61.77-149.34
Cash Dividends Paid2.61-467.890.00-2.57-17.08-459.02
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-327.22-168.89-406.35-492.79-170.290.00
Repurchase of Common Pref Stock-327.22-168.89-406.35-492.79-170.290.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-53.5314.31163.74498.76-464.15774.23
Change in Long Term Debt83.64-386.1942.57558.51-537.65866.49
Issuance of Long Term Debt114.54122.5154.09574.1453.611,195.64
Reduction of Long Term Debt-30.90-508.69-11.51-15.63-591.26-329.15
Net Financing Active Other Cash Flow-93.94-95.28-91.54-80.87-441.48-60.18
Other Financing Activities Uses-93.94-95.28-91.54-80.87-441.48-60.18
Cash from Financing Activities-651.97-903.96-516.97-253.37-1,290.8472.51
Exchange Rate Effect17.442.4521.89-37.12-22.04-77.53
Net Change in Cash47.98-207.76-421.14388.90-501.13693.16
Free Cash Flow646.38724.8043.08662.80661.64664.46
Price to Free Cash Flow7.317.568.008.9510.199.53

Revenue breakdown

Consolidation, Policy2024: 1.82B 2025: 2.49B
Health Care Products2024: 4.53B 2025: 4.88B
Health Care Services2024: 14.58B 2025: 14.77B
Foreign countries2024: 20.40B 2025: 21.58B
Germany2024: 518.22M 2025: 557.84M
Care Delivery2024: 14.63B 2025: 14.93B
Care Enablement2024: 4.39B 2025: 4.67B
Value-Based Care2024: 1.90B 2025: 2.53B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.58%3.0M519.0M924.58K
2026-10-150.74%4.0M532.2M800.69K
2026-09-300.53%2.8M532.2M712.36K
2026-09-150.52%2.8M532.2M665.66K
2026-08-310.52%2.8M532.2M699.61K
2026-08-140.52%2.8M532.2M733.94K
2026-07-310.50%2.7M532.2M764.64K
2026-07-150.55%2.7M490.5M753.04K
2026-06-300.60%2.9M490.5M727.69K
2026-06-150.58%2.8M490.5M713.61K
2026-05-290.45%2.2M490.5M682.90K
2026-05-150.24%1.2M490.5M649.92K
2026-04-300.26%1.4M539.8M575.20K
2026-04-150.28%1.6M558.2M614.10K
2026-03-310.31%1.7M558.2M637.74K
2026-03-130.33%1.8M558.2M612.89K
2026-02-270.37%2.1M558.2M592.29K
2026-02-130.32%1.9M579.3M564.64K
2026-01-300.40%2.3M579.3M562.12K
2026-01-150.39%2.3M579.3M481.19K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call12.508.1011.500.005.2350.000.000.931-0.0720.005
call15.005.609.100.004.1010.000.000.909-0.0670.006
call17.503.306.605.702.9560.000.000.875-0.0600.008
call20.000.704.203.201.63562.000.000.747-0.0860.012
call22.500.003.001.501.2382280.000.558-0.0760.015
call25.000.002.651.370.7756.000.000.249-0.0470.012
call30.000.002.600.001.4830.000.000.154-0.0670.009
put12.500.002.600.002.9220.000.00-0.068-0.0730.005
put15.000.002.600.002.1920.000.00-0.090-0.0680.006
put17.500.000.400.101.5573890.00-0.124-0.0600.008
put20.000.000.900.051.4209520.00-0.252-0.0860.012
put22.500.002.900.500.8251,0850.00-0.441-0.0750.015
put25.001.053.903.502.1635.000.00-0.750-0.0470.012
put30.005.908.700.002.9230.000.00-0.845-0.0660.009

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-096-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-09SEC
2026-11-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-30SEC
2026-11-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-11-03SEC
2026-10-076-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-10-07SEC
2026-09-256-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-09-25SEC
2026-08-276-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-27SEC
2026-08-24SCHEDULE 13D/ASEC
2026-08-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-06-30SEC
2026-08-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-03SEC
2026-08-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-03SEC
2026-08-036-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-08-03SEC
2026-07-296-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-07-29SEC
2026-07-28SCHEDULE 13GSEC
2026-06-2911-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC
2026-05-286-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-28SEC
2026-05-28SDSpecialized Disclosure ReportSEC
2026-05-266-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-26SEC
2026-05-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-03-31SEC
2026-05-056-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-05-05SEC
2026-04-146-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-04-14SEC
2026-03-183Initial statement of beneficial ownership of securities2026-03-18SEC
2026-02-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-24SEC
2026-02-24IRANNOTICENotice of Iran-related disclosure filed pursuant to Section 13(r)(3) of the Exchange ActSEC
2026-02-2420-FRegistration statement under Section 12 of the Securities Exchange Act of 1934 or an annual or transition report filed under Section 13(a) or 15(d) of the Exchange Act for a foreign private issuer.2025-12-31SEC
2026-02-246-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-02-24SEC
2026-01-126-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162026-01-12SEC
2026-01-09SCHEDULE 13D/ASEC
2025-12-106-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-12-10SEC
2025-11-176-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-11-17SEC
2025-11-046-KCurrent report of foreign issuer pursuant to Rules 13a-16 and 15d-162025-09-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
PZENA INVESTMENT MANAGEMENT LLC3.12%
MORGAN STANLEY0.89%
DODGE & COX0.78%
FIDUCIARY MANAGEMENT INC /WI/0.60%
BRANDES INVESTMENT PARTNERS, LP0.39%
TODD ASSET MANAGEMENT LLC0.33%
MILLENNIUM MANAGEMENT LLC0.32%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY0.21%
GOLDMAN SACHS GROUP INC0.18%
BlackRock, Inc.0.18%

Funds

Fund% owned
VANGUARD WINDSOR FUND1.67%
Dodge & Cox Balanced Fund0.78%
VANGUARD SELECTED VALUE FUND0.52%
Liberty All-Star Equity Fund0.23%
FMI Large Cap Fund0.21%
Hennessy Cornerstone Growth Fund0.06%
Pzena Mid Cap Value Fund0.02%
Pzena U.S. Large Cap Value ETF0.02%
NIA IMPACT SOLUTIONS FUND0.01%
Steward Values Enhanced International Fund0.01%

OakChart. FMS. Cached 15 minutes.

Some panels did not load: insider.